TELA Bio, Inc. (NASDAQ: TELA) reported Q4 EPS of ($0.17), $0.01 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $20.9 million versus the consensus estimate of $21.04 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.